5-HYDROXYMETHYL LUMIRACOXIB
UNII BWY4M9ECD7

Substance Identification & Data

This profile provides standardized clinical and technical data for 5-hydroxymethyl Lumiracoxib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BWY4M9ECD7.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 697287-16-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
BWY4M9ECD7
CAS Registry Number
697287-16-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
5-HYDROXYMETHYL LUMIRACOXIB
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C15H13ClFNO3
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
PREBINJQDJNORC-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
N(c1c(Cl)cccc1F)c2c(CC(=O)O)cc(cc2)CO

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 5-hydroxymethyl Lumiracoxib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

5-HYDROXYMETHYL LUMIRACOXIB

Systematic Nomenclature

BENZENEACETIC ACID, 2-((2-CHLORO-6-FLUOROPHENYL)AMINO)-5-(HYDROXYMETHYL)-
LUMIRACOXIB METABOLITE M21